AAA
Affinity Asset Advisors’s Perspective Therapeutics CATX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.61M | Sell |
1,050,000
-1,174,196
| -53% | -$4.04M | 0.49% | 44 |
|
|
2025
Q1 | $4.74M | Buy |
2,224,196
+924,196
| +71% | +$1.97M | 0.45% | 36 |
|
|
2024
Q4 | $4.15M | Buy |
1,300,000
+800,000
| +160% | +$2.55M | 0.56% | 36 |
|
|
2024
Q3 | $6.68M | Sell |
500,000
-50,000
| -9% | -$668K | 0.91% | 34 |
|
|
2024
Q2 | $5.48M | Sell |
550,000
-4,550,000
| -89% | +$399K | 0.63% | 39 |
|
|
2024
Q1 | $6.07M | Buy |
+5,100,000
| New | +$6.07M | 0.75% | 33 |
|